These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2194315)

  • 1. Antithrombin III Kumamoto: identification of a point mutation and genotype analysis of the family.
    Ueyama H; Murakami T; Nishiguchi S; Maeda S; Hashimoto Y; Okajima K; Shimada K; Araki S
    Thromb Haemost; 1990 Apr; 63(2):231-4. PubMed ID: 2194315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of antithrombin III (ATIII) variants using polymerase chain reaction. Identification of the ATIII Charleville as an Ala 384 Pro mutation.
    Molho-Sabatier P; Aiach M; Gaillard I; Fiessinger JN; Fischer AM; Chadeuf G; Clauser E
    J Clin Invest; 1989 Oct; 84(4):1236-42. PubMed ID: 2794060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Identification of a nature of mutation in the 12th exon of phenylalanine hydroxylase gene in patients with phenylketonuria].
    Skriabin BV; Koval'chuk LA; Khal'chitskiĭ SE; Gol'tsov AA; Kaboev OK; Plutalov OV; Berlin IuA; Shvarts EI
    Bioorg Khim; 1989 Dec; 15(12):1690-2. PubMed ID: 2634967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An alternate nonisotopic technique of PCR-mediated allele-specific oligonucleotide analysis for the detection of a point mutation.
    Nakajima H; Hamaguchi T; Tomita K; Uenaka R; Yamagata K; Hanafusa T; Kuwajima M; Noguchi T; Tanaka T; Kono N
    Res Commun Chem Pathol Pharmacol; 1993 Jan; 79(1):3-10. PubMed ID: 8434131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombin III Nagasaki (Ser116-Pro): a heterozygous variant with defective heparin binding associated with thrombosis.
    Okajima K; Abe H; Maeda S; Motomura M; Tsujihata M; Nagataki S; Okabe H; Takatsuki K
    Blood; 1993 Mar; 81(5):1300-5. PubMed ID: 8443391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis for hereditary antithrombin III quantitative deficiencies: a stop codon in exon IIIa and a frameshift in exon VI.
    Gandrille S; Vidaud D; Emmerich J; Clauser E; Sié P; Fiessinger JN; Alhenc-Gelas M; Priollet P; Aiach M
    Br J Haematol; 1991 Jul; 78(3):414-20. PubMed ID: 1873224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis for antithrombin III type I deficiency: three novel mutations located in exon IV.
    Vidaud D; Emmerich J; Sirieix ME; Sié P; Alhenc-Gelas M; Aiach M
    Blood; 1991 Nov; 78(9):2305-9. PubMed ID: 1932746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of a point mutation using short oligonucleotide probes in allele-specific hybridization.
    Iitiä A; Mikola M; Gregersen N; Hurskainen P; Lövgren T
    Biotechniques; 1994 Sep; 17(3):566-73. PubMed ID: 7818911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The confirmation of preclinical familial antithrombin deficiency using polymorphism and specific oligonucleotide probes .
    Beresford CH; Hughes PM; Olds R
    N Z Med J; 1990 Jun; 103(892):296-8. PubMed ID: 1973278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical and genetic aspects of antithrombin III deficiency and abnormal antithrombin III].
    Tsuji H
    Rinsho Ketsueki; 1991 May; 32(5):481-6. PubMed ID: 1870264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombin III Kumamoto II; a single mutation at Arg393-His increased the affinity of antithrombin III for heparin.
    Okajima K; Abe H; Wagatsuma M; Okabe H; Takatsuki K
    Am J Hematol; 1995 Jan; 48(1):12-8. PubMed ID: 7832187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insertions/deletions in the antithrombin gene: 3 mutations associated with non-expression.
    Daly M; Perry DJ; Harper PL; Daly HM; Roques AW; Carrell RW
    Thromb Haemost; 1992 May; 67(5):521-5. PubMed ID: 1325679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
    Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
    Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CpG dinucleotides are "hotspots" for mutation in the antithrombin III gene. Twelve variants identified using the polymerase chain reaction.
    Perry DJ; Carrell RW
    Mol Biol Med; 1989 Jun; 6(3):239-43. PubMed ID: 2615648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two mutations in exon XII of the protein S alpha gene in four thrombophilic families resulting in premature stop codons and depressed levels of mutated mRNA.
    Andersen BD; Lind B; Philips M; Hansen AB; Ingerslev J; Thorsen S
    Thromb Haemost; 1996 Aug; 76(2):143-50. PubMed ID: 8865520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis for congenital deficiency of alpha 2-plasmin inhibitor. A frameshift mutation leading to elongation of the deduced amino acid sequence.
    Miura O; Hirosawa S; Kato A; Aoki N
    J Clin Invest; 1989 May; 83(5):1598-604. PubMed ID: 2496145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel mutation (E113X) of antithrombin III gene (AT3) in a woman with gestational recurrent thrombosis.
    Yamada H; Hoshi N; Kato EH; Ebina Y; Kishida T; Sagawa T; Matsuno K; Fujimoto S
    Am J Med Genet; 2000 Apr; 91(5):348-50. PubMed ID: 10766996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metachromatic leukodystrophy: identification of the first deletion in exon 1 and of nine novel point mutations in the arylsulfatase A gene.
    Draghia R; Letourneur F; Drugan C; Manicom J; Blanchot C; Kahn A; Poenaru L; Caillaud C
    Hum Mutat; 1997; 9(3):234-42. PubMed ID: 9090526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for mutations in the antithrombin III gene causing recurrent venous thrombosis by single-strand conformation polymorphism analysis.
    Millar DS; Lopez A; White D; Abraham G; Laursen B; Holding S; Reverter JC; Reynaud J; Martinowitz U; Hayes JP
    Hum Mutat; 1993; 2(4):324-6. PubMed ID: 8401542
    [No Abstract]   [Full Text] [Related]  

  • 20. Homozygous or compound heterozygous qualitative antithrombin III deficiency.
    Cucuianu M; Blaga S; Pop S; Olinic D; Olinic N; Colhon D; Cristea A
    Nouv Rev Fr Hematol (1978); 1994 Aug; 36(4):335-7. PubMed ID: 7971256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.